BCDA BioCardia, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$1.04
· of 52w range
· above low
· to high
$0.7552w low
$1.8052w high
Market Cap (MRQ)
$16M
Revenue
$0
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$16
P/E
·
ROE
1660.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
BCDA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.04
Market Cap (MRQ)
$16M
Revenue
$0
ROE
1660.5%
52W Range
$1–$2
BCDA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 30, 2024 | 1-for-15 | Reverse |
| June 6, 2019 | 1-for-9 | Reverse |
| Nov. 3, 2017 | 1-for-12 | Reverse |
| March 14, 2008 | 1-for-10 | Reverse |
| Jan. 6, 2004 | 6-for-1 | Forward |
| Aug. 23, 2001 | 1-for-3 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02016-12-31 → 2025-12-31
Free Cash Flow$-7M2017-12-31 → 2025-12-31
Net margin·2017-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BCDA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 5.85Y avg ≈-18.0 | ≈-18.0 | · | · | |
| Price / FCF (TTM) | -2.15Y avg ≈-18.3 | ≈-18.3 | · | · | |
| Price / Cash Flow (TTM) | -2.15Y avg ≈-18.5 | ≈-18.5 | · | · | |
| Price / Tangible Book | 12.55Y avg ≈50.7 | ≈50.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BCDA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -230.6%5Y avg ≈-178.2% | ≈-178.2% | · | · | |
| ROE | 1660.5%5Y avg ≈533.6% | ≈533.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BCDA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.15Y avg ≈1.6 | ≈1.6 | 1.3 | Strong liquidity | |
| Quick Ratio | 1.05Y avg ≈1.5 | ≈1.5 | 1.1 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | BCDA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -87.8%5Y avg ≈120.2% | ≈120.2% | · | · | |
| Revenue CAGR 3Y | -61.5% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BCDA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.0 | ≈0.0 | · | · | |
| Receivables Turnover | 0.05Y avg ≈2.7 | ≈2.7 | · | · | |
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
14.5%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.13 | $-0.18 | 29.2% |
| March 31, 2026 | May 15, 2026 | $-0.21 | $-0.17 | -24.8% |
| Dec. 31, 2025 | $-0.06 | $-0.17 | 65.4% | |
| Sept. 30, 2025 | $-0.24 | $-0.23 | -2.3% | |
| June 30, 2025 | $-0.40 | $-0.51 | 21.6% | |
| March 31, 2025 | $-0.59 | $-0.40 | -48.3% | |
| Dec. 31, 2024 | $-0.25 | $-0.64 | 60.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | · | |
| Cost of Revenue | · | · | · | · | $0 | $4.0K | $358.0K | $517.0K | $690.0K | $746.0K | $1M | · | |
| R&D Expense | $5M | $4M | $8M | $9M | $9M | $10M | $9M | $8M | $6M | $3M | $2M | · | |
| SG&A Expense | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $6M | $6M | $4M | $4M | $196.0K | |
| Operating Expenses | $8M | $8M | $12M | $13M | $14M | $16M | $15M | $15M | $13M | $8M | $6M | · | |
| Operating Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-16M | $-14M | $-14M | $-12M | $-8M | $-5M | $231.0K | |
| Interest Expense | · | · | · | · | $0 | $3.0K | $112.0K | · | · | $2M | $1M | · | |
| Interest Income | · | · | · | · | $9.0K | $21.0K | · | · | · | · | · | · | |
| Other Non-op | $50.0K | $55.0K | $73.0K | $-6.0K | $7.0K | $-2.0K | $-2.0K | $-3.0K | $2.0K | $-2.0K | $-2.0K | · | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $322.0K | $234.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| EPS (Basic) | $-1.23 | $-2.90 | $-8.19 | $-0.67 | $-0.75 | · | · | · | · | · | · | · | |
| Shares (Basic) | 6,666,943 | 2,743,828 | 1,411,998 | 17,720,972 | 16,917,664 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | 230,293,141 | 230,293,141 | |
| EBITDA | $-8M | $-8M | $-12M | · | $-13M | $-15M | $-14M | $-14M | $-12M | · | $319.0K | $231.0K |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $1M | $7M | $13M | $21M | $6M | $5M | $13M | $21M | $4M | $3M | |
| Receivables | $20.0K | $0 | $63.0K | $201.0K | $147.0K | $232.0K | $147.0K | $274.0K | $95.0K | $74.0K | $107.0K | · | |
| Inventory | · | · | · | · | · | · | $4.0K | $141.0K | $191.0K | $135.0K | $759.0K | · | |
| Prepaid Expense | $216.0K | $251.0K | $295.0K | $300.0K | $462.0K | $401.0K | · | $445.0K | $340.0K | $356.0K | $146.0K | $36.0K | |
| Current Assets | $3M | $3M | $1M | $8M | $13M | $23M | $6M | $6M | $13M | $22M | $5M | · | |
| PP&E (Net) | $16.0K | $33.0K | $94.0K | $170.0K | $182.0K | $145.0K | $181.0K | $145.0K | $169.0K | $111.0K | $150.0K | · | |
| PP&E (Gross) | $801.0K | $794.0K | $788.0K | $789.0K | $719.0K | $1M | $1M | $990.0K | $927.0K | $882.0K | $882.0K | · | |
| Accum. Depreciation | $785.0K | $761.0K | $694.0K | $619.0K | $537.0K | $1M | $957.0K | $845.0K | $758.0K | $771.0K | $732.0K | · | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $43.0K | · | |
| Total Assets | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Accounts Payable | $641.0K | $385.0K | $890.0K | $683.0K | $507.0K | $746.0K | $914.0K | $743.0K | $902.0K | $525.0K | $542.0K | $10.0K | |
| Accrued Liabilities | $34.0K | $22.0K | $75.0K | $157.0K | $240.0K | $87.0K | $10.0K | $127.0K | $465.0K | $478.0K | $692.0K | · | |
| Current Liabilities | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $1M | $8M | · | |
| Capital Leases | $86.0K | $566.0K | $982.0K | $1M | $2M | $0 | $614.0K | · | · | · | · | · | |
| Total Liabilities | $3M | $3M | $5M | $5M | $5M | $4M | $5M | $3M | $2M | $2M | $8M | $10.0K | |
| Common Stock | $11.0K | $5.0K | $2.0K | $20.0K | $17.0K | $16.0K | $7.0K | $5.0K | $38.0K | $38.0K | $19.0K | $230.0K | |
| Paid-in Capital | $169M | $161M | $151M | $145M | $139M | $135M | $103M | $90M | $84M | $81M | $341.0K | $26M | |
| Retained Earnings | $-168M | $-160M | $-152M | $-141M | $-129M | $-116M | $-101M | $-86M | $-72M | $-60M | $-50M | $-12M | |
| Stockholders' Equity | $895.0K | $837.0K | $-2M | $5M | $10M | $19M | $2M | $4M | $11M | $21M | $-3M | $-43M | |
| Liabilities + Equity | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Shares Outstanding | 10,755,647 | 4,600,910 | 1,577,769 | 20,076,773 | 16,871,265 | 16,297,381 | 6,825,183 | 4,845,697 | 38,218,660 | 38,131,303 | 18,947,536 | 230,293,141 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K | $68.0K | $111.0K | $88.0K | $78.0K | $39.0K | $47.0K | · | |
| Stock-based Comp | $430.0K | $741.0K | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $942.0K | $283.0K | $0 | |
| Other Non-cash | $338.0K | $-888.0K | $483.0K | · | $536.0K | $-373.0K | $2M | $56.0K | $852.0K | · | · | · | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-12M | $-9M | $-11M | $-9M | $-6M | $-7M | $214.0K | |
| CapEx | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K | $32.0K | $146.0K | $66.0K | $136.0K | · | $125.0K | · | |
| Investing Cash Flow | $-7.0K | $-6.0K | $-12.0K | $-70.0K | $-116.0K | $-32.0K | $-146.0K | $-66.0K | $-136.0K | $19M | $-125.0K | · | |
| Stock Issued | $9M | $11M | $4M | $6M | $2M | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $9M | $11M | $4M | · | $2M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $9M | $4M | $5M | $2M | $28M | $10M | $4M | $144.0K | $4M | $8M | · | |
| Net Change in Cash | $125.0K | $1M | $-6M | $-6M | $-9M | $16M | $227.0K | · | · | · | $331.0K | $214.0K | |
| Free Cash Flow | $-7M | $-8M | $-10M | · | $-10M | $-12M | $-10M | $-11M | $-9M | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -13794.8% | -2441.1% | · | -1244.3% | -10709.7% | -2001.8% | -2256.3% | -2589.8% | · | · | · | |
| Net Margin | · | -13700.0% | -2425.8% | · | -1243.7% | -10347.6% | -2071.7% | -2237.9% | -2569.5% | · | · | · | |
| EBITDA Margin | · | -13679.3% | -2423.5% | · | -1238.4% | -10662.8% | -1986.2% | -2242.2% | -2573.5% | · | · | · | |
| ROA | -230.6% | -236.8% | -181.1% | · | -64.5% | -96.5% | -208.7% | -140.2% | -69.1% | · | 2.3% | 1.7% | |
| ROE | 1660.5% | -442.7% | 1022.6% | · | -106.1% | -128.8% | -388.9% | -415.3% | -77.6% | · | -2.2% | 1.7% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | 2.3% | 1.7% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 0.4 | · | 3.6 | 5.3 | 1.6 | 2.4 | 5.7 | · | · | · | |
| Quick Ratio | 1.0 | 1.0 | 0.3 | · | 3.5 | 5.1 | 1.4 | 2.2 | 5.5 | · | · | · | |
| Interest Coverage | · | · | · | · | · | -5176.3 | -126.9 | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Inventory Turnover | · | · | · | · | · | · | 4.9 | 3.1 | 4.2 | · | · | · | |
| Receivables Turnover | 0.0 | 1.8 | 3.6 | · | 5.4 | 0.8 | 3.4 | 3.4 | 5.7 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.18 | $-0.07 | · | $0.61 | $1.18 | $0.35 | $0.09 | $0.29 | · | $0.06 | $0.06 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash / Share | $0.23 | $0.52 | $0.05 | · | $0.76 | $1.31 | $0.82 | $0.12 | $0.33 | · | $0.06 | $0.06 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -87.8% | -64.7% | 33.2% | 600.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -61.5% | 48.7% | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | $47.0K | |
| Net Income TTM | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| Market Cap | $13M | $10M | $234M | · | $491M | $846M | $377M | $7.07B | $12.12B | · | $29.85B | $41.04B | |
| P/S | · | 172.9 | 491.2 | · | 483.7 | 5833.3 | 530.6 | 11304.0 | 25312.9 | · | 33015.5 | 873154.0 | |
| P/B | 15.0 | 12.0 | -146.2 | · | 47.3 | 44.1 | 159.0 | 1863.1 | 1089.9 | · | 2152.5 | 3030.0 | |
| P / Tangible Book | 15.0 | 12.0 | · | 128.7 | 47.3 | 44.1 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -1.2 | -23.5 | · | -47.4 | -68.4 | -39.9 | -638.3 | -1398.3 | · | 90169.2 | 191767.5 | |
| P / FCF | -1.8 | -1.2 | -23.5 | · | -46.8 | -68.3 | -39.3 | -634.5 | -1376.7 | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | $55.0K | $13.0K | $357.0K | $43.0K | $64.0K | $106.0K | $212.0K | |
| R&D Expense | $893.0K | $1M | $1M | $936.0K | $1M | $2M | $1M | $931.0K | $800.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $730.0K | $1M | $885.0K | $552.0K | $683.0K | $1M | $906.0K | $825.0K | $852.0K | $1M | $941.0K | $1M | $1M | $1M | $924.0K | $1M | |
| Operating Expenses | $2M | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| Other Non-op | $10.0K | $7.0K | $29.0K | $5.0K | $2.0K | $14.0K | $25.0K | $19.0K | $3.0K | $8.0K | $12.0K | $24.0K | $28.0K | $9.0K | $-10.0K | $3.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| EPS (Basic) | $-0.13 | $-0.21 | $0.00 | $-0.24 | $-0.40 | $-0.59 | $-0.06 | $-0.61 | $-0.88 | $-1.35 | $-3.71 | $-1.79 | $-2.52 | $-0.17 | $-0.17 | $-0.17 | |
| EPS (Diluted) | · | $-0.21 | · | · | $-0.40 | $-0.59 | · | · | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 12,093,268 | 10,812,419 | · | 6,277,848 | 5,059,736 | 4,635,764 | · | 2,827,492 | 1,877,069 | 1,675,539 | · | 1,441,043 | 1,358,968 | 20,177,167 | · | 17,844,991 | |
| Shares (Diluted) | · | 10,812,419 | · | · | 5,059,736 | 4,635,764 | · | · | · | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $-2M | · | $-1M | $-2M | $-3M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $951.0K | $2M | $5M | $980.0K | $949.0K | $2M | $5M | $1M | $949.0K | $1M | $2M | $4M | $5M | $7M | $7M | |
| Receivables | $30.0K | $20.0K | $20.0K | · | $10.0K | · | $0 | $10.0K | $10.0K | $58.0K | $63.0K | $104.0K | $115.0K | $153.0K | $201.0K | $300.0K | |
| Prepaid Expense | $151.0K | $169.0K | $216.0K | $78.0K | $209.0K | $224.0K | $251.0K | $116.0K | $142.0K | $252.0K | $295.0K | $177.0K | $230.0K | $279.0K | $300.0K | $187.0K | |
| Current Assets | $4M | $1M | $3M | $5M | $1M | $1M | $3M | $5M | $2M | $1M | $1M | $2M | $5M | $5M | $8M | $7M | |
| PP&E (Net) | $13.0K | $16.0K | $16.0K | $13.0K | $17.0K | $21.0K | $33.0K | $47.0K | $61.0K | $75.0K | $94.0K | $114.0K | $139.0K | $158.0K | $170.0K | $189.0K | |
| PP&E (Gross) | $804.0K | $804.0K | $801.0K | $795.0K | $795.0K | $794.0K | $794.0K | $793.0K | $791.0K | $788.0K | $788.0K | $788.0K | $801.0K | $799.0K | $789.0K | $787.0K | |
| Accum. Depreciation | $791.0K | $788.0K | $785.0K | $782.0K | $778.0K | $773.0K | $761.0K | $746.0K | $730.0K | $713.0K | $694.0K | $674.0K | $662.0K | $641.0K | $619.0K | $598.0K | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $171.0K | $172.0K | |
| Total Assets | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Accounts Payable | $541.0K | $820.0K | $641.0K | $1M | $1M | $818.0K | $385.0K | $569.0K | $1M | $1M | $890.0K | $507.0K | $686.0K | $861.0K | $683.0K | $887.0K | |
| Accrued Liabilities | $30.0K | $52.0K | $34.0K | $108.0K | $41.0K | $243.0K | $22.0K | $28.0K | $4.0K | $116.0K | $75.0K | $36.0K | $111.0K | $38.0K | $157.0K | $115.0K | |
| Current Liabilities | $2M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | |
| Capital Leases | $0 | $0 | $86.0K | $211.0K | $333.0K | $452.0K | $566.0K | $674.0K | $780.0K | $883.0K | $982.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Common Stock | $15.0K | $11.0K | $11.0K | $11.0K | $6.0K | $5.0K | $5.0K | $5.0K | $2.0K | $27.0K | $2.0K | $22.0K | $22.0K | $20.0K | $20.0K | $18.0K | |
| Paid-in Capital | $175M | $170M | $169M | $169M | $163M | $161M | $161M | $161M | $154M | $152M | $151M | $149M | $149M | $146M | $145M | $142M | |
| Retained Earnings | $-172M | $-171M | $-168M | $-166M | $-165M | $-163M | $-160M | $-158M | $-156M | $-154M | $-152M | $-150M | $-148M | $-144M | $-141M | $-138M | |
| Stockholders' Equity | $3M | $-1M | $895.0K | $3M | $-2M | $-2M | $837.0K | $3M | $-2M | $-2M | $-2M | $-660.0K | $2M | $2M | $5M | $4M | |
| Liabilities + Equity | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Shares Outstanding | 14,984,323 | 10,940,372 | 10,755,647 | 10,608,734 | 5,504,802 | 4,682,184 | 4,600,910 | 4,523,876 | 2,123,876 | 26,836,389 | · | 21,619,432 | 21,586,150 | 20,202,005 | · | 17,841,927 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $3.0K | $3.0K | $4.0K | $5.0K | $12.0K | $15.0K | $16.0K | $17.0K | $19.0K | $20.0K | $21.0K | $21.0K | $22.0K | $21.0K | $29.0K | |
| Stock-based Comp | $109.0K | $113.0K | $85.0K | $77.0K | $98.0K | $170.0K | $176.0K | $177.0K | $184.0K | $204.0K | $184.0K | $251.0K | $317.0K | $278.0K | $280.0K | $280.0K | |
| Other Non-cash | · | $484.0K | · | · | · | $912.0K | · | · | · | $514.0K | · | · | · | $641.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | |
| CapEx | $0 | $3.0K | $6.0K | $0 | $1.0K | $0 | $1.0K | $2.0K | $3.0K | $0 | $0 | $0 | $2.0K | $10.0K | $2.0K | $14.0K | |
| Investing Cash Flow | $0 | $-3.0K | $-6.0K | $0 | $-1.0K | $0 | $-1.0K | $-2.0K | $-3.0K | $0 | $0 | $0 | $-2.0K | $-10.0K | $-2.0K | $-14.0K | |
| Stock Issued | $5M | $225.0K | $0 | $7M | $2M | $212.0K | $39.0K | $7M | $2M | $1M | $1M | $92.0K | $3M | $244.0K | $4M | $139.0K | |
| Net Stock Activity | · | $225.0K | · | · | · | $212.0K | · | · | · | $1M | · | · | · | $244.0K | · | · | |
| Financing Cash Flow | $5M | $117.0K | $-288.0K | $6M | $2M | $196.0K | $-125.0K | $6M | $2M | $1M | $1M | $-58.0K | $3M | $64.0K | $4M | $73.0K | |
| Net Change in Cash | $3M | $-2M | $-3M | $4M | $31.0K | $-1M | $-3M | $4M | $472.0K | $-154.0K | $-732.0K | $-2M | $-552.0K | $-3M | $696.0K | $-2M | |
| Free Cash Flow | · | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -54966.7% | -4136.4% | · | -727.7% | -8027.9% | -5484.4% | · | -1443.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -54866.7% | -4121.8% | · | -721.0% | -7962.8% | -5470.3% | · | -1442.0% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -54966.7% | -4101.8% | · | -727.7% | -8027.9% | -5450.0% | · | -1443.4% | |
| ROA | -47.1% | -116.5% | · | -23.9% | -82.3% | -111.9% | · | -34.7% | -35.5% | -46.2% | · | -39.8% | -38.8% | -35.1% | · | -23.1% | |
| ROE | -396.3% | 174.7% | · | -55.1% | 106.5% | 142.9% | · | -166.0% | 1009.8% | 1209.1% | · | -149.8% | -81.8% | -75.5% | · | -34.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 0.4 | · | 1.6 | 0.3 | 0.4 | · | 1.8 | 0.4 | 0.3 | · | 0.6 | 1.3 | 1.3 | · | 1.9 | |
| Quick Ratio | 2.0 | 0.3 | · | 1.6 | 0.3 | 0.3 | · | 1.7 | 0.4 | 0.2 | · | 0.6 | 1.2 | 1.3 | · | 1.9 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 0.0 | · | · | 0.0 | 0.0 | 0.5 | · | 1.8 | 0.3 | 0.3 | · | 0.9 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.18 | $-0.10 | · | $0.25 | $-0.34 | $-0.32 | · | $0.61 | $-0.92 | $-0.08 | · | $-0.03 | $0.08 | $0.09 | · | $0.23 | |
| Cash Flow / Share | · | $-0.15 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.09 | · | $0.50 | $0.18 | $0.20 | · | $1.09 | $0.67 | $0.04 | · | $0.08 | $0.20 | $0.24 | · | $0.37 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $3.0K | · | $71.0K | $428.0K | $468.0K | · | $570.0K | $425.0K | $1M | · | $1M | |
| Net Income TTM | $-7M | $-8M | · | $-9M | $-9M | $-8M | · | $-8M | $-9M | $-10M | · | $-13M | $-13M | $-12M | · | $-12M | |
| Market Cap | $19M | $13M | · | $14M | $11M | $12M | · | $14M | $6M | $165M | · | $139M | $865M | $591M | · | $519M | |
| P/S | · | · | · | · | · | 3964.2 | · | 198.8 | 14.7 | 352.7 | · | 244.6 | 2034.2 | 435.8 | · | 391.8 | |
| P/B | 6.9 | -12.4 | · | 5.2 | -5.7 | -7.8 | · | 5.1 | -3.2 | -72.5 | · | -211.3 | 528.8 | 311.0 | · | 126.7 | |
| P / Tangible Book | 6.9 | · | · | 5.2 | · | · | · | 5.1 | · | · | · | · | 528.8 | 311.0 | · | 126.7 | |
| P / Cash Flow | · | -8.0 | · | · | · | -7.4 | · | · | · | -107.9 | · | · | · | -230.8 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $58.0K | $477.0K | $1M | $1M |
| Operating Margin % | · | -13794.8% | -2441.1% | · | -1244.3% |
| Net Income | $-8M | $-8M | $-12M | $-12M | $-13M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 0.4 | · | 3.6 |
| Quick Ratio | 1.0 | 1.0 | 0.3 | · | 3.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-7M | $-8M | $-10M | · | $-10M |
Institutional owners (13F) 21 filers · $1.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
21
Value held
$1.8M
New positions
6
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (0 vs prior Q) | 5 (+1 vs prior Q) | 4 (-1 vs prior Q) | 3 (+1 vs prior Q) | +645K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| CITIGROUP INC | $493,017 | 397,594 | 27.40% | Shares |
| CM Management, LLC | $372,000 | 300,000 | 20.68% | Shares |
| VANGUARD GROUP INC | $169,452 | 135,561 | 9.42% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $154,493 | 124,591 | 8.59% | Shares |
| Pingora Partners LLC | $149,274 | 120,382 | 8.30% | Shares |
| UBS Group AG | $96,248 | 77,619 | 5.35% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $82,662 | 66,664 | 4.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $82,175 | 66,270 | 4.57% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48,123 | 38,809 | 2.67% | Shares |
| BROWN ADVISORY INC | $44,067 | 35,538 | 2.45% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $28,990 | 23,383 | 1.61% | Shares |
| CITADEL ADVISORS LLC | $28,465 | 22,956 | 1.58% | Shares |
| StoneX Group Inc. | $24,825 | 20,020 | 1.38% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $16,924 | 18,500 | 0.94% | Shares |
| Tower Research Capital LLC (TRC) | $3,952 | 3,187 | 0.22% | Shares |
| MORGAN STANLEY | $3,850 | 3,105 | 0.21% | Shares |
| Global Retirement Partners, LLC | $510 | 411 | 0.03% | Shares |
| GSA CAPITAL PARTNERS LLP | $16 | 12,862 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $11 | 9 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $1 | 1 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
Activists & 5%+ owners 26 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Blank Andrew Scott | May 22, 2025 | 5.50% | Initial filing | Board campaign | SEC |
| Daly Joseph Patrick | May 21, 2025 | 0.00% | Amendment | · | SEC |
| Phillip Frost, M.D., Frost Gamma Investments Trust ×13 filings | April 5, 2024 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | May 25, 2023 | · | Initial filing | Passive investment | SEC |
| Jim L. Allen ×2 filings | Jan. 9, 2023 | · | Initial filing | Passive investment | SEC |
| Simon H. Stertzer (2), Kimberly Stertzer (2), Stertzer Family Trust (2), Windrock Enterprises L.L.C. (2) ×4 filings | Jan. 9, 2023 | · | Initial filing | · | SEC |
| Roumell Asset Management, LLC ("RAM"), James C. Roumell (Roumell) ×2 filings | Feb. 7, 2022 | · | Initial filing | Passive investment | SEC |
| OPKO Health, Inc. ×2 filings | Oct. 23, 2019 | · | Initial filing | · | SEC |
| Andrew A. Brooks, M.D. ×4 filings | May 19, 2016 | · | Initial filing | · | SEC |
| Jonathan Brooks ×3 filings | May 18, 2016 | · | Initial filing | · | SEC |
| Mikhail Kvitnitsky ×2 filings | July 5, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 24, 2008 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 24, 2008 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 19, 2008 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | March 19, 2008 | · | Initial filing | · | SEC |
| Dr. Jane Hsiao, Ph. D. | March 18, 2008 | · | Initial filing | Passive investment | SEC |
| Glenn L. Halpryn | Jan. 15, 2008 | · | Initial filing | Passive investment | SEC |
| Steven Jerry Glauser, Steven Jerry Glauser Revocable Trust IRS ID | Jan. 15, 2008 | · | Initial filing | Passive investment | SEC |
| Stephen Bittel | Jan. 15, 2008 | · | Initial filing | Passive investment | SEC |
| Ernest M. Halpryn | Jan. 15, 2008 | · | Initial filing | Passive investment | SEC |
| Roy Israel S.S. or, Carla Israel S.S. or | Sept. 28, 2007 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | April 15, 2005 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | Jan. 18, 2005 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | March 12, 2004 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | March 17, 2003 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | Nov. 20, 2001 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 38 insiders · 10 officers · 22 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Peter Altman | President and CEO | Sept. 29, 2026 P | 384,885 | 30 | 0 | $65,582 |
| Steven D Rubin | Interim CEO and Interim CFO | Aug. 11, 2016 A | 302,822 | 0 | 0 | $0 |
| Andrew A Brooks | CEO | May 10, 2016 S | 0 | 0 | 0 | $0 |
| Glenn L Halpryn | CEO | Aug. 29, 2008 J | 533,312 | 0 | 0 | $0 |
| Roy Israel | Chairman,CEO & President | Sept. 26, 2007 S | 0 | 0 | 0 | $0 |
| David Mcclung | Chief Financial Officer | July 6, 2026 A | 114,245 | 0 | 0 | $0 |
| Edward M Gillis | Senior Vice President, Devices | July 6, 2026 A | 54,126 | 0 | 0 | $0 |
| Eric Duckers | Chief Medical Officer | Nov. 2, 2020 S | 12,088 | 0 | 0 | $0 |
| Phil Pesta | Vice President of Operations | June 30, 2020 F | 11,867 | 0 | 0 | $0 |
| Richard T Allen | Vice President of Quality | Feb. 1, 2018 A | 807,591 | 0 | 0 | $0 |
| Bill Facteau | Director | July 6, 2026 A | 13,123 | 0 | 0 | $0 |
| Marvin Slosman | Director | July 6, 2026 A | · | 0 | 0 | $0 |
| Blank Andrew Scott | Director | July 6, 2026 A | 634,023 | 0 | 0 | $0 |
| Jim L. Allen | Director | July 6, 2026 A | 109,661 | 0 | 0 | $0 |
| Jay M Moyes | Director | July 6, 2026 A | 54,267 | 0 | 0 | $0 |
| STERTZER SIMON H | Director | July 6, 2026 A | 166,338 | 2 | 0 | $103,584 |
| Richard M Krasno | Director | April 23, 2025 P | 16,268 | 0 | 0 | $0 |
| Krisztina M Zsebo | Director | April 14, 2022 A | 2,980 | 0 | 0 | $0 |
| Richard C Pfenniger JR | Director | Dec. 31, 2020 A | 51,970 | 0 | 0 | $0 |
| Fernando L Fernandez | Director | Sept. 30, 2020 A | 40,644 | 0 | 0 | $0 |
| Thomas Quertermous | Director | July 26, 2019 M | 15,681 | 0 | 0 | $0 |
| TESSLER ALLAN R | Director | July 26, 2019 M | 23,186 | 0 | 0 | $0 |
| Stephen H Liu | Director | Aug. 11, 2016 A | 75,000 | 0 | 0 | $0 |
| Subbarao V Uppaluri | Director | Aug. 11, 2016 A | 471,592 | 0 | 0 | $0 |
| Ronald N. Richards | Director | May 10, 2016 S | 0 | 0 | 0 | $0 |
| Thomas H. Morgan | Director | May 10, 2016 S | 40,419 | 0 | 0 | $0 |
| Jonathan Brooks | Director | May 10, 2016 S | 91,000 | 0 | 0 | $0 |
| Mikhail Kvitnitsky | 10% owner | July 1, 2011 S | 0 | 0 | 0 | $0 |
| Steven Jerry Glauser | · | Aug. 29, 2008 J | 7,865,768 | 0 | 0 | $0 |
| Kenneth W Good | · | Sept. 26, 2007 S | 0 | 0 | 0 | $0 |
| Willem F Specht | · | Sept. 26, 2007 S | 0 | 0 | 0 | $0 |
| Rheaume Patricia A Giuliani | · | Sept. 26, 2007 S | 0 | 0 | 0 | $0 |
| Robert M Silverson JR | · | June 30, 2004 A | · | 0 | 0 | $0 |
| Anthony J Mercorella | · | June 30, 2004 A | · | 0 | 0 | $0 |
| Correy J Gottlieb | · | June 30, 2004 A | · | 0 | 0 | $0 |
| Randy Gerstenblatt | · | June 30, 2004 A | · | 0 | 0 | $0 |
| Kenneth G Geraghty | · | June 30, 2004 A | · | 0 | 0 | $0 |
| Alan Littman | · | June 4, 2004 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
BCDA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$15.50
+1390.4%
2 25.0%
Strong Buy
5 62.5%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-30Mean target $15.50 +1390.4%
← Below all targets
Current price $1.04
Low$6.00
Mean$15.50
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026